To evaluate the clinical significance of TMEM86B in colorectal cancer, we analyzed data from the GEPIA2 database, which showed that elevated TMEM86B expression was significantly associated with poorer prognosis in colon cancer patients (Figure 11B). Here, TMEM86B is linked to colonic neoplasm.